Pharmacokinetics and pharmacodynamics of the short-acting sedative CNS 7056 in sheep
| dc.contributor.author | Upton, R. | |
| dc.contributor.author | Somogyi, A. | |
| dc.contributor.author | Martinez, A. | |
| dc.contributor.author | Colvill, J. | |
| dc.contributor.author | Grant, C. | |
| dc.date.issued | 2010 | |
| dc.description.abstract | Background: CNS 7056 is a new short-acting esterase-metabolized benzodiazepine. We report the first pharmacokinetic (PK) and pharmacodynamic (PD) study of CNS 7056 and its inactive metabolite CNS 7054 in sheep. Methods: The stability of CNS 7056 in blood samples was examined ex vivo. Six sheep were prepared with physiological instrumentation, and were given doses of 0.37, 0.74, and 1.47 mg kg−1 (2 min infusion) of CNS 7056 in alternating order on separate days. Results: CNS 7056 was degraded in warm whole sheep blood (23% over 2 h), but not in plasma or blood stored on ice. Using non-compartmental analysis (NCA), CNS 7056 had a mean (sd) clearance of 4.52 (0.96) litre min−1 and a terminal half-life of 21.3 (10.9) min. There was a rapid conversion of CNS 7056 to its metabolite CNS 7054, which had a terminal half-life of 22.5 (3.4) min. The arterial kinetics of CNS 7056 could be described by a three-compartment model, with volumes of 1.9, 3.9, and 79 litre, a clearance of 4.2 litre min−1, and inter-compartmental clearances of 2.85 and 1.44 litre min−1, while the metabolite could be described by a two-compartment model. Cardiac output was an important covariate. Sedation as measured by the alpha power band of the EEG showed rapid onset and offset. The t1/2,ke0 for sedation was 1.78 min, and the EC50 was 0.10 µg ml−1. Conclusions: CNS 7056 has PK–PD properties compatible with its potential human use as a short-acting i.v. sedative. | |
| dc.description.statementofresponsibility | R. N. Upton, A. A. Somogyi, A. M. Martinez, J. Colvill and C. Grant | |
| dc.identifier.citation | British Journal of Anaesthesia, 2010; 105(6):798-809 | |
| dc.identifier.doi | 10.1093/bja/aeq260 | |
| dc.identifier.issn | 0007-0912 | |
| dc.identifier.issn | 1471-6771 | |
| dc.identifier.orcid | Upton, R. [0000-0001-9996-4886] | |
| dc.identifier.orcid | Somogyi, A. [0000-0003-4779-0380] | |
| dc.identifier.uri | http://hdl.handle.net/2440/62066 | |
| dc.language.iso | en | |
| dc.publisher | Oxford Univ Press | |
| dc.rights | © The Author [2010]. Published by Oxford University Press on behalf of the British Journal of Anaesthesia. All rights reserved. | |
| dc.source.uri | https://doi.org/10.1093/bja/aeq260 | |
| dc.subject | benzodiazepine | |
| dc.subject | cardiac output | |
| dc.subject | CNS 7056 | |
| dc.subject | pharmacodynamics | |
| dc.subject | pharmacokinetics | |
| dc.subject | sedation | |
| dc.subject | sheep | |
| dc.title | Pharmacokinetics and pharmacodynamics of the short-acting sedative CNS 7056 in sheep | |
| dc.type | Journal article | |
| pubs.publication-status | Published |